Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial
Zakrzewska, Joanna M, Palmer, Joanne, Morisset, Valerie, Giblin, Gerard MP, Obermann, Mark, Ettlin, Dominik A, Cruccu, Giorgio, Bendtsen, Lars, Estacion, Mark, Derjean, Dominique, Waxman, Stephen G, LVolume:
16
Langue:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(17)30005-4
Date:
April, 2017
Fichier:
PDF, 357 KB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
